查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888749

美國硬膜密封劑和纖維蛋白黏合劑市場規模、佔有率和趨勢分析報告（按 CPT 手術代碼、最終用途和細分市場預測，2025-2035 年）

U.S. Dural Sealants And Fibrin Glues Market Size, Share & Trends Analysis Report By CPT Procedure Code (61510 / 61512, 61320 - 61323, 61518, 62140 / 62141, 63707, 63709, 63710), By End Use, And Segment Forecasts, 2025 - 2035
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

預計到 2024 年，美國杜拉爾密封劑和纖維蛋白黏合劑市場規模將達到 65.7 億美元，到 2035 年將達到 109.9 億美元。

預計從 2025 年到 2035 年，該行業將以 4.78% 的複合年成長率成長。這一成長是由神經外科和脊椎手術數量的增加所驅動的，特別是複雜的顱內手術、後顱窩手術和脊椎硬膜成形術，在這些手術中，防止腦脊髓液漏至關重要。

Dykhouse 等人於 2024 年發表在《神經外科雜誌·脊柱分冊》上的一項研究表明，美國脊柱手術數量持續穩定成長，從 2013 年的約 80 萬例增加到 2022 年的超過 110 萬例。這一成長與退化性脊椎疾病的快速增加、人口老化以及手術安全性的提高（尤其是在老年患者中）密切相關。

醫院和門診手術中心優先選擇能夠確保傷口水密閉合、減少術後併發症並支持以價值為導向的治療結果的密封劑和黏合劑。聚乙二醇（PEG）基水凝膠、膠原蛋白移植物和合成密封劑等先進產品的日益普及、有利的報銷政策以及不斷成長的門診手術量，都在推動市場進一步擴張。醫院和手術中心優先選擇能夠最大限度減少腦脊髓液（CSF）漏、縮短恢復時間和降低再入院率的產品。根據美國醫療保健研究與品質署（AHRQ）統計，術後腦脊髓液漏佔神經外科併發症的3%至8%，且通常需要再次手術。這些再次手術不僅每次增加約25,000至4萬美元的額外費用，還會顯著延長住院時間並增加感染風險。

此外，機器人輔助手術和影像導引手術（IGS）的加速普及為硬膜密封劑和纖維蛋白黏合劑在美國開闢了清晰的成長路徑。隨著神經外科醫生和脊椎團隊向精準手術平台轉型，對可靠、相容於微創手術流程且能在有限手術視野內實現可預測、完全閉合的輔助產品的需求日益成長。 2025年發表於Cureus的一項科學計量學分析檢驗了脊椎手術中硬膜密封劑的研究趨勢。結果顯示，約40%的研究源自美國，且近期研究主題已從「密封劑類型」轉向「臨床結果、安全性、有效性和工作流程整合」。

此外，MPO雜誌2025年10月發表的一篇關於手術機器人行業的綜述說明，手術平台正進入一個“新階段”，強調軟體主導的差異化、門診手術流程的重新設計以及與輔助設備的兼容性。這些數據表明，先進的手術平台（機器人/術中介入手術）與血管內輔助技術的融合日益加深，為適用於這些環境的密封劑和黏合劑創造了巨大的需求動力。這些因素共同推動了市場成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章美國杜拉爾密封劑和纖維蛋白黏合劑市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關及輔助市場展望
  • 市場動態
  • 美國杜拉爾密封劑和纖維蛋白黏合劑市場分析工具
    • 波特分析
    • PESTEL 分析

第4章美國硬膜密封劑和纖維蛋白黏合劑市場：按CPT程序代碼分類的估算和趨勢分析

  • 美國硬膜密封劑和纖維蛋白黏合劑市場：按 CPT 程序代碼分類的差異分析
  • 美國硬膜密封劑和纖維蛋白黏合劑市場：按 CPT 手術代碼分類的展望
  • 市場規模、預測與趨勢分析（2024-2035）
  • 61510/61512-開顱切除上腦室病變
  • 61320-61323-減壓性顱骨切除術或減壓性顱骨切除術（伴或不伴硬腦膜成形術）
  • 61518-後顱窩病變開顱手術
  • 62140/62141-顱骨成形術或硬腦膜重組
  • 63707 - 不經切除術術修復顱內或脊髓液漏
  • 63709 - 腦脊髓液漏或假性腦膜膨出切除術術修補
  • 63710-硬膜移植（脊椎）
  • 63030 -切除術/腰椎切除術，神經根減壓手術
  • 63047-切除術（腰椎，1 個或多個椎體）
  • 22612/22630-後路脊椎融合手術減壓術

第5章美國杜拉爾密封劑和纖維蛋白黏合劑市場：按最終用途分類的估算和趨勢分析

  • 美國硬質密封劑和纖維蛋白黏合劑市場：按最終用途分類的變化分析
  • 美國硬質密封劑和纖維蛋白黏合劑市場：按最終用途分類的展望
  • 市場規模、預測與趨勢分析（2024-2035）
  • 醫院
  • 門診手術中心
  • 專科診所

第6章 競爭情勢

  • 市場參與企業分類
  • 主要企業簡介
    • Integra LifeSciences
    • Stryker
    • Baxter
    • Ethicon（J&J;）
    • Takeda Pharmaceutical
    • B. Braun Medical
    • Cook Medical
    • Polyganics
Product Code: GVR-4-68040-810-6

Market Size & Trends:

The U.S. dural sealants and fibrin glues market size was valued at USD 6.57 billion in 2024 and is expected to reach USD 10.99 billion by 2035, growing at a CAGR of 4.78% from 2025 to 2035. Growth is driven by increasing neurosurgical and spinal procedure volumes, particularly complex cranial, posterior fossa, and spinal duraplasty cases where cerebrospinal fluid (CSF) leak prevention is critical.

According to a 2024 study published in the Journal of Neurosurgery: Spine by Dykhouse et al., spine procedure volumes in the U.S. increased from approximately 800,000 in 2013 to over 1.1 million in 2022, representing a steady and sustained growth. This expansion is closely linked with a surge in degenerative spine disorders, aging demographics, and improved surgical safety, particularly for older patients.

Hospitals and ambulatory surgical centers prioritize sealants and glues that ensure watertight closure, reduce postoperative complications, and support value-based outcomes. The rising adoption of advanced products, such as PEG-based hydrogels, collagen grafts, and synthetic sealants, along with favorable reimbursement and increasing outpatient surgical volumes, further fuels market expansion. Hospitals and surgical centers are prioritizing products that minimize cerebrospinal fluid (CSF) leaks, shorten recovery times, and lower readmission rates. According to the Agency for Healthcare Research and Quality (AHRQ), postoperative CSF leaks account for up to 3-8% of neurosurgical complications, often requiring revision surgery. These reoperations not only elevate costs by nearly USD 25,000-USD 40,000 per case, but also significantly extend hospital stays and increase infection risk.

Moreover, the accelerating adoption of robotic-assisted and image-guided surgery (IGS) presents a clear growth pathway for dural sealants and fibrin glues in the U.S. As neurosurgeons and spine teams migrate toward precision platforms, demand rises for adjunctive products that are reliable, compatible with minimally invasive workflows, and deliver predictable watertight closure in constrained operative fields. A 2025 scientometric analysis published in Cureus reviewed the publication trends for dural sealants in spine surgery. It found that nearly 40% of research originates in the U.S., and recent research topics have shifted from "types of sealants" to "clinical outcomes, safety, efficacy, and workflow integration".

Furthermore, an industry review of surgical robotics published by MPO Magazine in October 2025 described the field entering a "new phase" where platforms emphasize software-led differentiation, outpatient redesign and compatibility with adjunct devices. These data points demonstrate a growing intersection between advanced surgical platforms (robotics/IGS) and dural adjunct technologies, creating a substantive momentum for sealants and glues optimized for these environments. These factors are collectively contributing to the growth of market.

U.S. Dural Sealants And Fibrin Glues Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each sub-segments from 2024 to 2035. For this study, Grand View Research has segmented the U.S. dural sealants and fibrin glues market report based on CPT procedure codes and end use:

  • CPT Procedure Codes Outlook (Revenue, USD Unit, 2024 - 2035)
  • 61510 / 61512 - Craniotomy for supratentorial lesion removal
  • 61320 - 61323 - Craniectomy or craniotomy, decompressive (with or without duraplasty)
  • 61518- Craniotomy for infratentorial/posterior fossa lesion
  • 62140 / 62141- Cranioplasty or dural reconstruction
  • 63707- Repair of CSF leak, cranial or spinal, without laminectomy
  • 63709 - Repair of CSF leak or pseudomeningocele with laminectomy
  • 63710- Dural graft (spinal)
  • 63030 - Laminotomy/laminectomy (lumbar), decompression of nerve root
  • 63047 - Laminectomy, >1 vertebral segment, lumbar
  • 22612 / 22630 - Posterior spinal fusion with decompression
  • End Use Outlook (Revenue, USD Unit, 2024 - 2035)
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. CPT Procedure Codes
    • 1.2.2. End Use
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. CPT Procedure Codes
    • 2.2.2. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Dural Sealants and Fibrin Glues Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising neurosurgical and spinal procedures
      • 3.2.1.2. Focus on patient safety and reduced reoperations
      • 3.2.1.3. Breakthrough biomaterials driving next-gen dural repair
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Unnecessary back surgeries limiting ethical utilization
      • 3.2.2.2. Availability of alternative techniques
  • 3.3. U.S. Dural Sealants and Fibrin Glues Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. U.S. Dural Sealants and Fibrin Glues Market: CPT Procedure Codes Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Dural Sealants and Fibrin Glues Market: CPT Procedure Codes Movement Analysis
  • 4.3. U.S. Dural Sealants and Fibrin Glues Market by CPT Procedure Codes Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2024 to 2035 for the following
  • 4.5. 61510 / 61512 - Craniotomy for Supratentorial Lesion Removal
    • 4.5.1. 61510 / 61512 - Craniotomy for Supratentorial Lesion Removal Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
  • 4.6. 61320 - 61323 - Craniectomy or Craniotomy, Decompressive (With or Without Duraplasty)
    • 4.6.1. 61320 - 61323 - Craniectomy or Craniotomy, Decompressive (With or Without Duraplasty) Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
  • 4.7. 61518- Craniotomy for Infratentorial/Posterior Fossa Lesion
    • 4.7.1. 61518- Craniotomy for Infratentorial/Posterior Fossa Lesion Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
  • 4.8. 62140 / 62141- Cranioplasty or Dural Reconstruction
    • 4.8.1. 62140 / 62141- Cranioplasty or Dural Reconstruction Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
  • 4.9. 63707- Repair of CSF Leak, Cranial or Spinal, Without Laminectomy
    • 4.9.1. 63707- Repair of CSF Leak, Cranial or Spinal, Without Laminectomy Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
  • 4.10. 63709 - Repair of CSF Leak or Pseudomeningocele with Laminectomy
    • 4.10.1. 63709 - Repair of CSF Leak or Pseudomeningocele with Laminectomy Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
  • 4.11. 63710- Dural Graft (Spinal)
    • 4.11.1. 63710- Dural Graft (Spinal) Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
  • 4.12. 63030 - Laminotomy/Laminectomy (Lumbar), Decompression of Nerve Root
    • 4.12.1. 63030 - Laminotomy/Laminectomy (Lumbar), Decompression of Nerve Root Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
  • 4.13. 63047 - Laminectomy, >1 Vertebral Segment, Lumbar
    • 4.13.1. 63047 - Laminectomy, >1 Vertebral Segment, Lumbar Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
  • 4.14. 22612 / 22630 - Posterior Spinal Fusion with Decompression
    • 4.14.1. 22612 / 22630 - Posterior Spinal Fusion with Decompression Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)

Chapter 5. U.S. Dural Sealants and Fibrin Glues Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Dural Sealants and Fibrin Glues Market: End Use Movement Analysis
  • 5.3. U.S. Dural Sealants and Fibrin Glues Market by End Use Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2024 to 2035 for the following
  • 5.5. Hospitals
    • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
  • 5.6. Ambulatory Surgical Centers
    • 5.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)
  • 5.7. Specialty Clinics
    • 5.7.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2024 - 2035 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Key Company Profiles
    • 6.2.1. Integra LifeSciences
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Stryker
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Baxter
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Ethicon (J&J)
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Takeda Pharmaceutical
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. B. Braun Medical
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Cook Medical
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Polyganics
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. dural sealants and fibrin glues market, by CPT procedure codes, 2024 - 2035 (USD Million)
  • Table 4 U.S. dural sealants and fibrin glues market, by end use, 2024 - 2035 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. dural sealants and fibrin glues: market outlook
  • Fig. 9 U.S. dural sealants and fibrin glues market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 U.S. dural sealants and fibrin glues market driver impact
  • Fig. 15 U.S. dural sealants and fibrin glues market restraint impact
  • Fig. 16 U.S. dural sealants and fibrin glues market strategic initiatives analysis
  • Fig. 17 U.S. dural sealants and fibrin glues market: CPT procedure codes movement analysis
  • Fig. 18 U.S. dural sealants and fibrin glues market: CPT procedure codes outlook and key takeaways
  • Fig. 19 61510 / 61512 - Craniotomy for supratentorial lesion removal market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 20 61320 - 61323 - Craniectomy or craniotomy, decompressive (with or without duraplasty) market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 21 61518- Craniotomy for infratentorial/posterior fossa lesion market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 22 62140 / 62141- Cranioplasty or dural reconstruction market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 23 63707- Repair of CSF leak, cranial or spinal, without laminectomy market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 24 63709 - Repair of CSF leak or pseudomeningocele with laminectomy market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 25 63710- Dural graft (spinal) market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 26 63030 - Laminotomy/laminectomy (lumbar), decompression of nerve root market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 27 63047 - Laminectomy, >1 vertebral segment, lumbar market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 28 22612 / 22630 - Posterior spinal fusion with decompression market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 29 U.S. dural sealants and fibrin glues market end use movement analysis
  • Fig. 30 U.S. dural sealants and fibrin glues market, end- use outlook key takeaways
  • Fig. 31 Hospitals market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 32 Ambulatory surgical centers market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 33 Specialty clinics market revenue estimates and forecasts, 2024 - 2035 (USD Million)
  • Fig. 34 Participant categorization- U.S. dural sealants and fibrin glues market
  • Fig. 35 Market share of key market players- U.S. dural sealants and fibrin glues market